Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-32 of 32 (Search time: 0.228 seconds).
Issue DateTitleAuthor(s)
2021Results from an Open-Label, Phase 1/2 Study of Frontline Brentuximab Vedotin Plus Adriamycin, Vinblastine, and Dacarbazine in Pediatric Patients with Advanced Stage Hodgkin LymphomaFRANKLIN, A.; LUISI, F.; PIANOVSKI, M.; SALVINO, M.; FAGIOLI, F.; EPELMAN, S.; LIMA, L. B. De Abreu; NORRIS, R.; FILHO, V. O.; ZECCA, M.; FAVRE, C.; KOBAYASHI, R.; KOGA, Y.; SIDI, Y.; CAMPANA, F.; LEONARD, E. J.; LOCATELLI, F.
2022Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A plus AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL).FRANKLIN, Anna Rachel Keating; LUISI, Flavio; PIANOVSKI, Mara; SALVINO, Marco Aurelio; FAGIOLI, Franca; EPELMAN, Sidnei; LIMA, Luciana; NORRIS, Robin Elizabeth; ODONE-FILHO, Vicente; ZECCA, Marco; FAVRE, Claudio; KOBAYASHI, Ryoji; KOGA, Yuhki; SIDI, Yulia; ZHOU, Xiaofei; BAI, Xiang; CAMPANA, Frank; LEONARD, E. Jane; LOCATELLI, Franco